
MALAT-1 is Associated with the Doxorubicin Resistance in U-2OS Osteosarcoma Cells
Author(s) -
Chang Liu,
Xuesong Han,
Bo Li,
Shaobin Huang,
Zhou Zhong,
Zhiwei Wang,
Wanming Wang
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s304922
Subject(s) - osteosarcoma , doxorubicin , cancer research , cisplatin , apoptosis , mapk/erk pathway , cell growth , chemistry , kinase , biology , medicine , chemotherapy , biochemistry
Our study aimed to investigate the relationship between MALAT-1 (metastasis-associated lung adenocarcinoma transcript 1) expression and the chemotherapy drug resistance in osteosarcoma.